Fuchs' Endothelial Corneal Dystrophy clinical trials at UC Health

• A Research Study of Experimental Ripasudil Eye Drops in Fuchs Endothelial Corneal Dystrophy

  open to eligible people ages 18 years and up

  The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.

  at UC Davis UCLA

Last updated: March 3, 2021